ST. PETERSBURG, Fla., June 6, 2011 /PRNewswire/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN;NYSE: SNN) today announced the launch of ALLEVYN Gentle Border Sacrum, a new dressing that incorporates Gentle Border technology and is designed specifically for managing wounds located in the sacral area. Also launching today is Classroom to Bedside, a new professional education program focused on skin and wound care. These new tools, introduced at the 2011 Wound, Ostomy and Continence Nurses Society (WOCN) Annual Conference, further the company's commitment to providing nurses and other care providers with the resources and products that contribute to positive patient outcomes.
The Classroom to Bedside Education Program will help nurses and other healthcare professionals by providing resources and tools to support optimal assessment and management of wounds, reduce clinical practice variation and improve the patient experience. This new program provides the training and tools to take caregivers from the classroom to the bedside. The program uses a series of teaching modules, training DVDs, pocket guides and bedside tools to provide guidance for pressure ulcer prevention, wound assessment and documentation, management of non-healing wounds and the use of advanced wound care dressings and negative pressure wound therapy.
"At Smith & Nephew we work closely with WOCN providers to address their changing needs and enable the best level of care," said Patricia Burns, Smith & Nephew's Vice President of Clinical Affairs for Advanced Wound Management. "We are pleased to introduce this new product and education program as they demonstrate our long-standing commitment to innovation and education."
ALLEVYN Gentle Border Sacrum technology incorporates a silicone gel adhesive suitable for fragile or sensitive skin to minimize pain during dressing changes. ALLEVYN Gentle Border Sacrum is indicated to treat exuding, granulating wounds located on or near the sacrum, or at the base of the spine. The unique anatomical design was developed based on clinical input and is able to conform to the distinctive contours of the sacral area, providing flexibility and gentle adherence.
These new offerings by Smith & Nephew build on the company's pledge to advance the practice of wound care and reduce the overall human and economic cost of wounds. For more information on ALLEVYN Gentle Border Sacrum or the Classroom to Bedside Education Program, please go to www.smith-nephew.com or visit us at the WOCN Conference, Booth #833.
The ALLEVYN range of wound dressings are comprised of three layers: a breathable bacteria proof and waterproof polyurethane top film, a hydrocellular absorbent foam core and a non-adherent wound contact layer. This Triple Action Technology provides moisture balance for support of the natural wound healing process. ALLEVYN dressings come in a variety of shapes and sizes and are designed to treat a large variety of wounds in various locations around the body.
About Smith & Nephew
Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy, including Sports Medicine; and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions and our success in integrating acquired businesses; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.
Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.
*Trademark of Smith & Nephew. Certain marks registered U.S. Patent and Trademark Office.
SOURCE Smith & Nephew